CANKADO E-HEALTH SUPPORT FOR INSTITUT JULES BORDET’s NEW STUDY, STOMRAY

Cologne, Germany, 30.09.2020 – CANKADO, the leading digital health application developers to be the e-health support for Institute Jules Bordet’s new clinical study that tests the dental side effects of radiotherapy on patients with head and neck cancer.

As an academic non-for-profit organisation, the Clinical Trials Support Unit (CTSU) of the comprehensive cancer centre Institut Jules Bordet (IJB) is fighting cancer through the design, set-up and conduct of innovative clinical trials that matters to patients.  The  recent study titled “Prospective pilot study evaluating dental side effects of radiotherapy on subjects treated for head and neck cancer ” or shortly titled as ‘StomRay’ sponsored by the Institut Jules Bordet aims to understand the radiotherapy side-effects causing dental problems in the head and neck cancer patients. Indeed, dental and/or oral side-effects during and after cancer treatment are common in head and neck cancer patients, as the radiotherapy can slow down the growth of new cells.  

The CANKADO e-health system helps to collect the patient reported outcomes recorded electronically or ePRO to test the quality of life and treatment-related symptoms. In this new project of Institut Jules Bordet, CANKADO Service GmbH, will be the academic partner to support the clinical study by adapting the CANKADO e-health system to the trial-specific requirements of ‘StomRay’. With this recent study, the data can be collected from cancer patients and thus help medical professionals to decide on the changes in the intervention.

About Institut Jules Bordet

Institut Jules Bordet is an integrated multidisciplinary center internationally recognized, unique in Belgium and is a hospital entirely dedicated to patients suffering from cancerous diseases. The CTSU is a department of the Jules Bordet Institute helping researchers in the development and conduct of exploratory (so-called phase 0), phases I, II and III clinical trials sponsored by the IJB for all cancer types. The CTSU manages the operational aspects of these academic trials in close collaboration with oncologists, surgeons and radiotherapists.